Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers
This study is testing two programs, "Recovering Together after Cardiac Arrest 1" and "Recovering Together after Cardiac Arrest 2," to help cardiac arrest survivors and their caregivers manage emotional distress, anxiety, and depression. "Recovering Together after Cardiac Arrest 1" teaches resilience skills like mindfulness and coping. "Recovering Together after Cardiac Arrest 2" provides information about available support resources. The study is looking for cardiac arrest survivors and their primary caregivers, aged 18 and older. The main goal is to see if these programs are practical to offer and if people are willing to participate. The study is currently unclear about its recruitment status.
- Study design
- This study is an interventional pilot randomized controlled trial involving 84 participants (42 survivor-caregiver pairs). Participants will be randomly assigned to one of two groups.
- What's involved
- If you are in the "Recovering Together after Cardiac Arrest 1" group, you will have six weekly 30-minute sessions, starting in person and continuing over Zoom. If you are in the "Recovering Together after Cardiac Arrest 2" group, you will have one 30-minute session in person. All participants will complete surveys at the beginning, after six weeks, and three months later.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for three months after the end of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Feasibility of Recruitmentpre-test
Proportion of eligible dyads that consent to participation
- Feasibility of RandomizationThe end of treatment at 6 weeks
Proportion of randomized participants who submit post-test assessments
- Feasibility of Assessment Completionpre-test, the end of treatment at 6 weeks, and 3 months after the end of treatment
Proportion of participants with no assessment measures missing at pre-test, post-test, and 3 month follow-up
- Feasibility of Program Adherence (RT-CA 1)the end of treatment at 6 weeks
Proportion of RT-CA 1 dyads that initiate the program by attending session 1 and complete at least 4 of 6 sessions.
- Therapist Fidelitythe end of treatment at 6 weeks
Proportion of 20% randomly-selected RT-CA 1 sessions in which the therapist fully adheres to program content, ascertained by a fidelity checklist
- Treatment Satisfaction (RT-CA 1)the end of treatment at 6 weeks
Proportion of RT-CA 1 participants that endorse satisfaction, defined as above the midpoint on the Client Satisfaction Questionnaire-3
- Credibility (RT-CA 1)pre-test
Proportion of RT-CA 1 participants that endorse program credibility at pre-test, defined as scoring above the midpoint on the Credibility sub scale of the Credibility/Expectancy Questionnaire
- Expectancy (RT-CA 1)pre-test
Proportion of RT-CA 1 participants that endorse expectancy to improve. from the program at pre-test, defined as scoring above the midpoint on the Expectancy sub scale of the Credibility/Expectancy Questionnaire
- Study safetyat the end of treatment at 6 weeks and 3 months after the end of treatment
The proportion of participants that report no adverse events related to study participation.